DUBLIN - (Business Wire) Research and Markets (http://www.researchandmarkets.com/research/f190cf/the_pharmaceutical) has announced the addition of the "The Pharmaceutical Market: Morocco" report to their offering. Morocco has entered a new phase of development with the adoption of a modern legal framework for the pharmaceutical sector. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Includes 3 quarterly updated outlook reports!
Situated in the north-west corner of Africa, the Islamic Kingdom of Morocco is the closest of the African countries to Europe, the northern port of Tangier forming a gateway to Spain, the other side of the Strait of Gibraltar.
The government has embarked on a major overhaul of the health sector, following two decades of under-funding and mismanagement. In addition to the modernisation and upgrading of existing facilities, the Ministry of Health's development programme includes the provision of three new teaching hospitals in Fez, Marrakech and Oujda.
The national health insurance scheme launched in 2005 is expected to provide substantial additional funding for the health sector. Initially aimed at salaried workers, the scheme has been expanded to cover the self-employed. The CNSS, which operates the scheme in the private sector, recently announced that it would be extending cover to ambulatory care in addition to hospital treatment. A health insurance scheme for those on very low incomes is still in the early stages of implementation and is now not expected to be rolled out on a national basis until 2010.
The Ministry of Health has launched an initiative to improve the uneven distribution of healthcare resources through two new planning tools, the health map and the regional strategic plan, which aim to promote greater co-ordination and co-operation between the public and private sectors.
In 2009, the health budget is programmed to increase by 20% in part to fund improved access to health services, particularly in rural areas. Spending on services and supplies is set to rise by 16.6% following a 72.5% increase in 2008, whilst capital investment will increase by 17.7%.
In September 2008, a revised list of reimbursable medical devices was published. The new list increases the number of devices reimbursable under the universal health insurance scheme from 172 to 869.
After a three-year period of stagnation, the medical market registered significant growth in 2003 and 2004 and is on course to reach US$154 million in 2009. However, per capita medical device spending remains low at less than US$5 and there is considerable potential for further expansion.
The local medical device manufacturing industry remains at an embryonic stage, leaving most sectors of the market reliant on foreign imports, which totaled US$124 million in 2007.
Key Topics Covered:
- Executive Summary
- Introduction
- Pharmaceutical Market Analysis
- Pharmaceutical Regulatory Analysis
- Pharmaceutical Distribution
- Healthcare Analysis
- Directory
Companies Mentioned:
- Laboratoire Afric-Phar
- Bottu
- Cooper Maroc
- Laboratoire Galenica
- Iberma
- Laprophan
- Pharmaceutical Institute
- Polymedic
- Promopharm
- Sothéma
- Bayer Pharma Maroc
- GlaxoSmithKline
- Pfizer
- Sanofi-Aventis
- Servier
- Cooper Maroc
- Sophasud
For more information visit http://www.researchandmarkets.com/research/f190cf/the_pharmaceutical
Source: Espicom Business Intelligence Ltd
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
